Based on our efficacy data in PDAC cell lines and Colo-357 tumor spheroids, we hypothesize that inhibition of mitochondrial KV1.3 ion channels is required for significant anticancer activity, as previously demonstrated with PAP-1-based mitochondrial KV1.3 inhibitors (PAPTP and PCARBTP). Here, KCNA3 is linked to neoplasm.